MedTrace Logo

: Intravascular Injection Rates During Cervical Medial Branch Block

NCT05031936 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2022-12-20

No results posted yet for this study

Summary

The purpose of this study is to compare using Toughy needle has an advantage of reducing intravascular injection rates during cervical medial branch block.

Conditions

  • Vascular Complications

Interventions

PROCEDURE

cervical spinal injection with 0.2% ropivacaine

spinal injections performed in cervical pillar area to relieve chronic neck pain

Sponsors & Collaborators

  • Keimyung University Dongsan Medical Center

    lead OTHER

Principal Investigators

  • Ji Hee Hong · Keimyung University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-12
Primary Completion
2022-10-30
Completion
2022-10-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05031936 on ClinicalTrials.gov